Related Experiment Video
Updated: Nov 2, 2025

Imaging CD4 T Cell Interstitial Migration in the Inflamed Dermis
Published on: March 25, 2016
CD1-Restricted T Cells in Inflammatory Skin Diseases
Samantha Genardi1, Eva Morgun1, Chyung-Ru Wang1
1Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Nonconventional T cells, specifically CD1-restricted T cells, play a role in autoimmune skin diseases by recognizing self-lipids. Understanding their aberrant regulation is key to addressing conditions like psoriasis and atopic dermatitis.
Area of Science:
- Immunology
- Dermatology
Background:
- Autoimmunity arises from a loss of immune tolerance, causing inflammation and disease.
- While conventional T cells in autoimmunity are well-researched, nonconventional T cells' roles remain less understood.
- CD1-restricted T cells, which recognize lipid antigens, are linked to autoimmune skin disorders such as psoriasis and atopic dermatitis.
Purpose of the Study:
- To review the self-lipids recognized by CD1-restricted T cells.
- To explore the aberrant regulation of these T cells in pathogenic skin conditions.
Main Methods:
- Literature review of studies on CD1-restricted T cells and autoimmunity.
- Analysis of self-lipids presented by CD1 molecules.
- Examination of T cell regulatory mechanisms in skin autoimmune diseases.
Main Results:
- CD1-restricted T cells are implicated in the pathogenesis of autoimmune skin conditions.
- Specific self-lipids are identified as antigens recognized by these T cells.
- Aberrant regulation of CD1-restricted T cells contributes to skin inflammation and pathology.
Conclusions:
- CD1-restricted T cells are significant players in autoimmune skin diseases.
- Further research into self-lipid recognition and T cell regulation is crucial for developing targeted therapies.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

